Stockscreener 앱 받기
15.88
6.04%
-1.12
전일 마감가:
$17.00
열려 있는:
$17.02
하루 거래량:
1.95M
Relative Volume:
0.32
시가총액:
$2.95B
수익:
$93.95M
순이익/손실:
$-129.87M
주가수익비율:
-17.64
EPS:
-0.9
순현금흐름:
$-202.88M
1주 성능:
-10.11%
1개월 성능:
+128.52%
6개월 성능:
+136.64%
1년 성능:
+19.97%
1일 변동 폭
$15.52
$17.03
1주일 범위
$15.52
$18.05
52주 변동 폭
$5.28
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
WVE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
15.87 | 3.16B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.86 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.73 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.62 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.90 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.65 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 재확인 | Wedbush | Outperform |
| 2025-12-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-04 | 개시 | Canaccord Genuity | Buy |
| 2025-07-28 | 개시 | Oppenheimer | Outperform |
| 2025-07-16 | 개시 | Citigroup | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Wedbush | Outperform |
| 2025-02-25 | 개시 | Jefferies | Buy |
| 2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 재개 | JP Morgan | Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-09-09 | 개시 | JP Morgan | Overweight |
| 2024-05-15 | 개시 | Wells Fargo | Overweight |
| 2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Raymond James | Outperform |
| 2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 개시 | Guggenheim | Buy |
| 2019-07-15 | 개시 | Cowen | Market Perform |
| 2019-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-08-07 | 개시 | Stifel | Buy |
| 2018-07-23 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2017-02-15 | 개시 | H.C. Wainwright | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-07 | 개시 | Jefferies | Buy |
| 2015-12-07 | 개시 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target - Insider Monkey
Moody Aldrich Partners LLC Lowers Stock Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
15 Best Stocks Under $25 to Buy Now - Insider Monkey
Wave Life Sciences’ (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss - Yahoo Finance
H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) - Finviz
Mid Cap Stocks To Watch TodayDecember 8th - MarketBeat
Voya Investment Management LLC Raises Stock Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next - ts2.tech
WAVE Life Sciences (STU:1U5) EV-to-OCF : -14.67 (As of Dec. 25, 2025) - GuruFocus
What New Catalysts Are Rewriting the Narrative for Wave Life Sciences? - Yahoo Finance
Behavioral Patterns of WVE and Institutional Flows - Stock Traders Daily
Wave Life Sciences (WVE) Is Up 11.7% After Early WVE-007 Fat-Loss DataWhat's Changed - simplywall.st
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
Oppenheimer and Truist lift Wave Life Sciences Ltd. (WVE) price targets after positive trial - MSN
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial - Insider Monkey
WAVE Life Sciences (NASDAQ:WVE) Stock Price Up 9.5%Still a Buy? - MarketBeat
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Analysts Offer Predictions for WVE Q1 Earnings - MarketBeat
Wave Life Sciences (WVE) price target increased by 60.82% to 32.70 - MSN
Wave Life Sciences (WVE) Price Target Increased by 60.82% to 32.70 - Nasdaq
Dividend Watch: Is Wave Life Sciences Ltd. stock attractive for income investorsWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - ulpravda.ru
Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat
HC Wainwright & Co. Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
WVE: HC Wainwright Raises Price Target to $30, Maintains Buy Rat - GuruFocus
Wave Life Sciences surges as obesity data reshapes long-term outlook - S&P Global
Market Catalysts: Is Wave Life Sciences Ltd. stock a smart buy before Fed meetingJuly 2025 PostEarnings & Stepwise Trade Execution Plans - Bölüm Sonu Canavarı
Will Wave Life Sciences Ltd. stock outperform tech sector in 2025Earnings Overview Report & Weekly Consistent Profit Watchlists - DonanımHaber
Is Wave Life Sciences Ltd. (1U5) stock positioned for digital growth era2025 Technical Overview & Consistent Profit Focused Trading Strategies - DonanımHaber
Will Wave Life Sciences Ltd. stock maintain growth storyPortfolio Update Report & Weekly Breakout Watchlists - Улправда
Is Wave Life Sciences Ltd. stock a smart buy before Fed meetingRate Cut & Low Volatility Stock Recommendations - DonanımHaber
Will Wave Life Sciences Ltd. stock keep outperforming rivalsJuly 2025 Analyst Calls & Stock Portfolio Risk Management - Улправда
Wave Life Sciences (WVE): Valuation Check After Positive WVE-007 Obesity Data And GlaxoSmithKline Backing - simplywall.st
Why Wave Life Sciences Ltd. stock is rated strong buy2025 Market Outlook & Safe Entry Point Identification - Улправда
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data - ts2.tech
WAVE Life Sciences (NASDAQ:WVE) Shares Down 4.3%Here's Why - MarketBeat
CEO Moves: Is Wave Life Sciences Ltd stock supported by innovation pipeline2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn
Wave Life Sciences (WVE) Is Down 19.2% After $350 Million Equity Raise On Obesity DataWhat's Changed - simplywall.st
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy - MSN
Share Offerings Prompt Huge Insider Buying in These 3 Biotechs - AOL.com
United StatesMintz Advises On Wave Life Sciences $402.5 Million Public Offering - Mondaq
Oppenheimer Maintains Wave Life Sciences (WVE) Outperform Recommendation - Nasdaq
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data By Investing.com - Investing.com South Africa
Medical Stocks To Watch TodayDecember 8th - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Oppenheimer Raises Price Target for WAVE Life Sciences (WVE) | W - GuruFocus
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Wave Life (WVE) shares nearly triple on encouraging obesity drug trial - MSN
Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128% - simplywall.st
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data - Investing.com India
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Wave Life Sciences Ltd 주식 (WVE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
42,000 |
250,740 |
54,700 |
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Sale |
15.00 |
42,000 |
630,000 |
12,700 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
14,000 |
83,580 |
51,930 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Sale |
13.50 |
14,000 |
189,000 |
44,930 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Option Exercise |
5.07 |
87,000 |
440,790 |
54,700 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Sale |
14.65 |
93,445 |
1,369,324 |
12,700 |
| Tan Aik Na | Director |
Dec 08 '25 |
Option Exercise |
4.85 |
119,230 |
578,270 |
70,400 |
| Tan Aik Na | Director |
Dec 08 '25 |
Sale |
13.58 |
134,218 |
1,823,158 |
25,400 |
| Verdine Gregory L. | Director |
Dec 08 '25 |
Sale |
13.47 |
20,000 |
269,461 |
275,217 |
| Francis Chris | See Remarks |
Dec 08 '25 |
Option Exercise |
4.78 |
441,031 |
2,107,183 |
147,349 |
0.22%
자본화:
|
볼륨(24시간):